Prosecution Insights
Last updated: August 16, 2026

Trustees of Boston University

19 pending office actions • 15 art units • 19 examiners • 0 of 19 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days

Portfolio Summary

19
Total Pending OAs
13
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
2
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 7 days (2)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (42%)
7
Medium (37%)
4
Easy (21%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only4 (21%)
§102 only1 (5%)
§112 only4 (21%)
Double-patenting + other2 (11%)
Multi-statute (no §101)8 (42%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
63% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
11% of docket
2
Mechanical / Eng
11% of docket
3
Business / Other
16% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
AKANBI, ISIAKA O 1 76.6% +22.9%
LEITH, NANCY J 1 74.7% +43.8%
LI, RUIXIANG 1 59.4% +19.1%
ROBERTS, BRIAN S 1 85.1% +3.2%
STOCK JR, GORDON J 1 81.4% +17.6%
OESTREICH, MITCHELL T 1 74.6% +20.5%
NGUYEN, HENRY H 1 63.8% +36.9%
LUKJAN, SEBASTIAN X 1 76.5% +40.8%
SUMLAR, JOURNEY F 1 69.0% +11.3%
BARSKY, JARED 1 50.3% +23.1%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18860160 MULTIPLE-INPUT MULTIPLE-OUTPUT ANTENNA RECEIVER WITH HYBRID ANALOG/DIGITAL BEAMFORMING ROBERTS, BRIAN S
18923191 FLUORESCENCE-CODED MID-INFRARED PHOTOTHERMAL MICROSCOPE STOCK JR, GORDON J

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
16771510 Inducible Cell Receptors for Cell-Based Therapeutics CHEONG, CHEOM-GIL 153d overdue
17793287 INDUCIBLE TISSUE CONSTRUCTS AND USES THEREOF MATALKAH, FATIMAH KHALAF 74d overdue
17182044 GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS GROSS, CHRISTOPHER M 53d overdue
18621968 NEUROMODULATION TECHNIQUES AND DEVICES RELATING THERETO LUKJAN, SEBASTIAN X 7d
18215420 INFUSION PUMP AND SYSTEM FOR PREVENTING MISCHANNELING OF MULTIPLLE MEDICAMENTS VU, QUYNH-NHU HOANG 15d
19174171 ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF LEITH, NANCY J 35d
18909517 EFFICIENT AND UNIFORM COLOR-LIGHT INTEGRATION DEVICE OESTREICH, MITCHELL T
18206947 METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS HUI, SAN MING R

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18621968 NEUROMODULATION TECHNIQUES AND DEVICES RELATING THERETO LUKJAN, SEBASTIAN X 7d
19174171 ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF LEITH, NANCY J 35d
19457731 INFRARED ABSORBANCE-MODULATED EVANESCENT SCATTERING MICROSCOPY AKANBI, ISIAKA O
19080346 ENGINEERED PROTEASE ACTIVITY RESPONSIVE RECEPTORS AND USES THEREOF LI, RUIXIANG
18923191 FLUORESCENCE-CODED MID-INFRARED PHOTOTHERMAL MICROSCOPE STOCK JR, GORDON J
18909517 EFFICIENT AND UNIFORM COLOR-LIGHT INTEGRATION DEVICE OESTREICH, MITCHELL T
18657525 DISPOSABLE FLUIDIC CARTRIDGE FOR INTERFEROMETRIC REFLECTANCE IMAGING SENSOR NGUYEN, HENRY H
18578671 OPTICAL SCAN MULTIPLIER AND USES THEREOF SUMLAR, JOURNEY F

Top Art Units

Art UnitApps
1684 2
2877 1
1636 1
1674 1
1758 1
3792 1
2872 1
1628 1
3783 1
1627 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19457731 INFRARED ABSORBANCE-MODULATED EVANESCENT SCATTERING MICROSCOPY AKANBI, ISIAKA O 2877 §103 Final Rejection Pending Jan 23, 2026
19174171 ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF LEITH, NANCY J 1636 §102§103 Final Rejection 35d Pending Apr 09, 2025
19080346 ENGINEERED PROTEASE ACTIVITY RESPONSIVE RECEPTORS AND USES THEREOF LI, RUIXIANG 1674 §112 Final Rejection Pending Mar 14, 2025
18860160 MULTIPLE-INPUT MULTIPLE-OUTPUT ANTENNA RECEIVER WITH HYBRID ANALOG/DIGITAL BEAMFORMING ROBERTS, BRIAN S §112 Non-Final OA Pending Oct 25, 2024
18923191 FLUORESCENCE-CODED MID-INFRARED PHOTOTHERMAL MICROSCOPE STOCK JR, GORDON J §102DP Non-Final OA Pending Oct 22, 2024
18909517 EFFICIENT AND UNIFORM COLOR-LIGHT INTEGRATION DEVICE OESTREICH, MITCHELL T §103§112 Non-Final OA Pending Oct 08, 2024
18657525 DISPOSABLE FLUIDIC CARTRIDGE FOR INTERFEROMETRIC REFLECTANCE IMAGING SENSOR NGUYEN, HENRY H 1758 §103 Final Rejection Pending May 07, 2024
18621968 NEUROMODULATION TECHNIQUES AND DEVICES RELATING THERETO LUKJAN, SEBASTIAN X 3792 §103§112 Non-Final OA 7d Pending Mar 29, 2024
18578671 OPTICAL SCAN MULTIPLIER AND USES THEREOF SUMLAR, JOURNEY F 2872 §103 Non-Final OA Pending Jan 11, 2024
18553474 Formulations for Prolonging Gestation and for Complications of Menstruation or Gestation BARSKY, JARED 1628 §102§103§112DP Non-Final OA Pending Sep 29, 2023
18215420 INFUSION PUMP AND SYSTEM FOR PREVENTING MISCHANNELING OF MULTIPLLE MEDICAMENTS VU, QUYNH-NHU HOANG 3783 §103§112 Non-Final OA 15d Pending Jun 28, 2023
18206947 METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS HUI, SAN MING R 1627 §103§112 Non-Final OA Pending Jun 07, 2023
17793287 INDUCIBLE TISSUE CONSTRUCTS AND USES THEREOF MATALKAH, FATIMAH KHALAF 1638 §103§112 Final Rejection 74d overdue Pending Jul 15, 2022
17763122 NOTCH RECEPTORS WITH ZINC FINGER-CONTAINING TRANSCRIPTIONAL EFFECTOR NGUYEN, QUANG 1631 §112Other Non-Final OA 5d overdue Pending Mar 23, 2022
17695073 STRUCTURED SUBSTRATES FOR OPTICAL SURFACE PROFILING FLINDERS, JEREMY C 1684 §102Other Non-Final OA 7d Pending Mar 15, 2022
17600957 METHODS OF PREDICTING AND PREVENTING CANCER IN PATIENTS HAVING PREMALIGNANT LESIONS ESSEX, LAURA ANN 1675 §112 Non-Final OA Pending Oct 01, 2021
17376138 SYNTHETIC HEPARIN MIMETICS AND USES THEREOF MACH, ANDRE 1615 §103 Non-Final OA Pending Jul 14, 2021
17182044 GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS GROSS, CHRISTOPHER M 1684 §102§103 Final Rejection 53d overdue Pending Feb 22, 2021
16771510 Inducible Cell Receptors for Cell-Based Therapeutics CHEONG, CHEOM-GIL 1645 §103§112 Non-Final OA 153d overdue Pending Jun 10, 2020

Managing Trustees of Boston University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month